A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants

NCT03953196 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Imvanex
BIOLOGICAL: Shingrix
BIOLOGICAL: LPS
BIOLOGICAL: Candin
OTHER: Skin Biopsy
OTHER: Saline Control

Sponsor

Janssen Research & Development, LLC